Abstract
Implication for health policy/practice/research/medical education In cases of refractory thrombotic thrombocytopenic purpura use of rituximab is appropriate.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
